Three Irish start-ups get €150,000 Phase 1 EU funding

12 May 20151 Share

Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Pin on PinterestShare on RedditEmail this to someone

Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Pin on PinterestShare on RedditEmail this to someone

Three Irish companies working in energy efficiency and pharmaceuticals are the latest to receive EU funding totalling €150,000 as part of Phase 1 of the Horizon 2020 programme.

Each company received an equal €50,000 in funding, with the first company being Dublin-based Aperilink, which works within the field of energy efficiency within the growing data centre network, something quite timely given regular news of Apple’s own plans to establish data centres in Ireland.

The second company, DiaNia Technologies, will use this funding to continue developing the next generation of catheter-based medical devices from its base in Galway.

And finally, Kerry-based IRIS Advanced Engineering will attempt to roll out its IR-spectroscopy-based platform (VISUM) that allows for real-time monitoring for the food and pharmaceutical industry.

The three companies were named among a total of 161 companies across 23 nations that received a total of more than €8m as part of Phase 1 funding where they hope to eventually progress to Phase 2 funding that would see them receive up to €2.5m each.

This round of funding will facilitate the development of feasibility studies.

Speaking of its success, Sinead Kenny, co-founder of DiaNia Technologies, said: “It’s a great boost to our confidence to have been selected from amongst 1,569 other SMEs from right across Europe – we are one of 161 which were selected in this round and only one of three from Ireland!”

EU Parliament buildings image via Shutterstock

 

Colm Gorey is a journalist with Siliconrepublic.com

editorial@siliconrepublic.com